scispace - formally typeset
A

Annika Lindblom

Researcher at Karolinska Institutet

Publications -  16
Citations -  932

Annika Lindblom is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Genome-wide association study & Colorectal cancer. The author has an hindex of 10, co-authored 16 publications receiving 573 citations. Previous affiliations of Annika Lindblom include Karolinska University Hospital & Malmö University.

Papers
More filters
Journal ArticleDOI

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Haoyu Zhang, +302 more
- 18 May 2020 - 
TL;DR: A genome-wide association study including 133,384 breast cancer cases and 113,789 controls plus 18,908 BRCA1 mutation carriers of European ancestry provides an improved understanding of genetic predisposition to breast cancer subtypes and will inform the development of subtype-specific polygenic risk scores.
Journal ArticleDOI

Novel Common Genetic Susceptibility Loci for Colorectal Cancer

Stephanie L. Schmit, +198 more
TL;DR: This article identified 42 loci (P < 5x10−8) associated with risk of colorectal cancer (CRC) and expanded consortium efforts facilitating the discovery of these loci.
Journal ArticleDOI

Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.

TL;DR: An expression-based strategy stratified the present "mutation-negative" cohort into two discrete categories: families linked to the major MMR genes MLH1, MSH2, and MSH6 and those likely to be associated with other, as yet unknown susceptibility genes.
Posted ContentDOI

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Haoyu Zhang, +312 more
- 24 Sep 2019 - 
TL;DR: A genome-wide association study including 133,384 breast cancer cases and 113,789 controls, plus 18,908 BRCA1 mutation carriers of European ancestry provides an improved understanding of genetic predisposition to breast cancer subtypes and will inform the development of subtype-specific polygenic risk scores.
Journal ArticleDOI

Long‐range PCR facilitates the identification of PMS2‐specific mutations

TL;DR: It is concluded that PMS2 mutation detection in selected Lynch syndrome and Lynch syndrome‐like patients is both feasible and desirable.